Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

182 results about "Gastrointestinal fluids" patented technology

Oxygen-containing heterocyclic compound salt as well as crystal form and application thereof

The invention discloses an oxygen-containing heterocyclic compound salt, and a crystal form and application thereof. The oxygen-containing heterocyclic compound salt disclosed by the invention has a structure as shown in a formula II. The oxygen-containing heterocyclic compound salt and the crystal form thereof provided by the invention have one or more improved characteristics, which are represented by extremely high water solubility, and high dissolution rate and high solubility in physiological related medium simulated gastrointestinal fluid, so that the stability of the oxygen-containing heterocyclic compound under an oxidation condition is remarkably improved, and the stability of the oxygen-containing heterocyclic compound is improved. Low hygroscopicity and good crystal form stability are achieved, and oral absorption and long-term storage of the medicine are facilitated; and the preparation method is simple and suitable for industrial production. # imgabs0 #
Owner:SHANGHAI YINGLI PHARMACEUTICAL CO LTD

Phytobacterium plantarum JN9, preparation, probiotic composition and application thereof

The invention relates to a plant lactobacillus JN9, a preparation, a probiotic composition and application thereof. According to the application, a new plant lactobacillus JN9 strain is obtained through screening, and the preservation number of the new plant lactobacillus JN9 strain is CCTCC (China Center for Type Culture Collection) NO: M 20241647. Through basic characteristic analysis (growth curve, acid resistance, cholate resistance and gastrointestinal fluid resistance), safety evaluation (antibiotic sensitivity, hemolysis capability, toxin production capability, cytotoxicity and biogenic amine production capability), adhesiveness evaluation, GABA production evaluation and alcohol tolerance and acetaldehyde dehydrogenase production capability evaluation of the strain, the strain is found to be a safe strain; and the GABA has excellent GABA production performance, high alcohol tolerance and high acetaldehyde dehydrogenase activity. The composition can be applied to products for improving mood, such as relieving pressure, resisting depression, improving body sleep quality, reducing blood pressure, resisting diabetes, resisting cancer, resisting oxidation, resisting inflammation, resisting microorganisms, resisting allergy, enhancing alcohol tolerance in drinking, relieving discomfort after drinking and the like.
Owner:ADM (SHANGHAI) MANAGEMENT CO LTD

Fermented lactobacillus mucus strain A21038 with anti-oxidation, anti-aging and anti-tumor activity and application of fermented lactobacillus mucus strain A21038

The invention provides a fermentation lactobacillus mucus strain A21038 with antioxidant activity, anti-aging activity and anti-tumor activity and application of the fermentation lactobacillus mucus strain A21038, and belongs to the technical field of functional microorganisms. The strain A21038 is separated and screened from intestinal feces of healthy old people of 100 years old, and belongs to lactobacillus mucilaginosus through morphological identification and molecular identification. The strain A21038 has good gastrointestinal fluid resistance and bovine choline resistance. The fermented lactobacillus mucus strain A21038 provided by the invention has bacteriostatic, anti-inflammatory, anti-oxidation and anti-tumor activity, and provides a new way for treatment of clinical related diseases, drug development and preparation of in-vitro preparations or daily necessities.
Owner:GUANGXI ACAD OF SCI +1

Micromolecular antibacterial polypeptide, preparation method therefor and use thereof

Provided is an antibacterial peptide having an amino acid sequence X1KRFKKFFX2KLKKWV-NH2, wherein X1 is selected from any one or of amino acids A, C, D, E, F, G, H, K, L, N, M, P, Q, R, S, I, V, W, Y, and T or is absent; and X2 is an amino acid having an aromatic side chain or an amino acid having an alkaline side chain. In view of defects such as poor gastrointestinal fluid stability of antibacterial peptides in the prior art, a brand-new sequence design scheme and preparation method for an antibacterial peptide are provided. By means of a complete or partial D-amino acid substitution or structural derivatization of a peptide sequence, a series of antimicrobial peptides having stronger antibacterial activity and gastrointestinal stability as compared with the prior art are obtained, such that the antibacterial peptides have a wider application range and higher development potential value.
Owner:SHENZHEN ICARBONX INTELLIGENT PEPTIDE PHARM TECH CO LTD

Pediococcus acidilactici NDF12 and application thereof

The invention discloses pediococcus acidilactici NDF12 and application thereof, the pediococcus acidilactici NDF12 is preserved in Guangdong Microbial Culture Collection Center on January 8, 2025, is called GDMCC for short, and the preservation number is GDMCC NO: 65732. The invention further discloses a preparation method of the pediococcus acidilactici NDF12. The strain is derived from Chinese local traditional dairy products, phenotype and genotype safety evaluation proves that the strain is safe and non-toxic, has excellent fermentation characteristics and probiotic characteristics, and can be used as a leavening agent for producing yoghourt. The bacterial strain also has gastrointestinal fluid endurance capacity, adhesion capacity, bacteriostatic activity, antioxidant activity, cholesterol lowering activity and blood sugar lowering activity, and has great application prospects in the fields of foods, medicines, feeds and the like.
Owner:SOUTH CHINA UNIV OF TECH

Micromolecular antibacterial polypeptide, preparation method and application thereof

The invention relates to the technical field of antibacterial drugs, in particular to an antibacterial peptide which has an amino acid sequence X1KRFKKFFX2KLKKWV-NH2, in which X1 is selected from any one or deletion of amino acids A, C, D, E, F, G, H, K, L, N, M, P, Q, R, S, I, V, W, Y and T; and X2 represents an amino acid having an aromatic side chain or an amino acid having a basic side chain. Aiming at the defects of poor gastrointestinal fluid stability and the like of the antibacterial peptide in the prior art, the invention provides a brand new antibacterial peptide sequence design scheme and a preparation method thereof, and the peptide sequence is subjected to full D-type amino acid or partial D-type amino acid replacement or structure derivation; compared with the prior art, a series of antibacterial peptides with higher antibacterial activity and gastrointestinal fluid stability are obtained, so that the antibacterial peptides have wider application range and higher potential development value.
Owner:SHENZHEN ICARBONX INTELLIGENT PEPTIDE PHARM TECH CO LTD

Lactobacillus rhamnosus strain with antiallergic activity and preparation method thereof

The invention discloses a lactobacillus rhamnosus strain with antiallergic activity and a preparation method thereof, the strain is lactobacillus rhamnosus Lrn-PG-06, the classification name of the strain is Lactobacillus rhamnosus, the preservation number is CGMCC (China General Microbiological Culture Collection Center) No.3077, the preservation time is March 21, 2024, the preservation unit is China General Microbiological Culture Collection Center, the preservation number is CGMCC No.3077, and the preservation number is CGMCC No.3077. The address is No.3, Yard 1, Beichen West Road, Chaoyang District, Beijing. The lactobacillus rhamnosus Lrn-PG-06 strain is high in acid resistance, alkali resistance and cholate resistance, high in simulated gastrointestinal fluid resistance and high in oxidation resistance, has the advantage of resisting allergy, and solves the problems that at present, allergic diseases are mainly treated by drugs or are prevented from being in contact with allergens in the environment and food, but due to the fact that the drugs are large in toxic and side effects, the allergens cannot be in contact with the allergens in the environment and food. And allergens causing anaphylaxis are difficult to determine, so that allergic diseases are difficult to treat or prevent.
Owner:HEILONGJIANG UNIV +1

Gastrointestinal fluid decompression device for gastrointestinal surgery

InactiveCN119055851Aavoid damageachieve the purpose of dredgingGastroscopesOesophagoscopesStomach tubesEndoscopy
The gastrointestinal fluid decompression device comprises a gastrointestinal fluid decompression assembly, an adjustable stomach tube protection inner sleeve, an endoscopic display mechanism and an anti-blocking device, the gastrointestinal fluid decompression assembly comprises a stomach tube body and a negative pressure extractor installed at the tail end of the stomach tube body, and an auxiliary cavity tube is machined and formed in an inner cavity of the stomach tube body; the adjustable stomach tube protection inner sleeve is installed on the stomach tube body and comprises a tail tube, a spherical protection cover, a pull wire and a rolling adjuster, the tail tube is fixed to the tail end of the stomach tube body, the spherical protection cover is arranged at the tail end of the tail tube, the inner side of the spherical protection cover is connected with the pull wire, and the pull wire penetrates through the auxiliary cavity tube and is connected with the rolling adjuster. The rolling regulator is installed on the front half section of the stomach tube body, and the endoscopic display mechanism is installed on the spherical protective cover. The designed efficient gastrointestinal fluid decompression device can achieve the purpose of decompression of the tail of a patient, can achieve the purpose of endoscopy when a stomach tube extends into the stomach tube, and improves the safety when the stomach tube is inserted into the stomach tube.
Owner:NANJING FIRST HOSPITAL

Application of breast milk-derived plant lactobacillus to improvement of allergic diseases and regulation of intestinal flora

The invention discloses an application of a breast milk-derived plant lactobacillus in improving allergic diseases and regulating intestinal flora, and belongs to the technical field of microorganisms. The plant lactobacillus GDMCC No: 63060 disclosed by the invention is obtained by being separated from breast milk. The strain provided by the invention has excellent gastrointestinal fluid tolerance, mucin adhesion and antibiotic sensitivity, can inhibit various pathogenic bacteria, can generate indole derivatives, effectively inhibits eczema mouse dermatitis symptoms, inhibits Th2 type immunoreaction hyperpolarization, and induces regulatory T cells. Therefore, the lactobacillus plantarum FN029 has a huge application prospect in preparation of products for inhibiting enteropathogenic bacteria, improving allergic diseases, regulating intestinal flora or promoting digestion function.
Owner:SHANGPIN HEALTH TECH (QINGDAO) CO LTD

Bifidobacterium animalis for relieving eye allergy and application thereof

PendingCN121592551ASenses disorderBacteriaDiseaseSwollen eyelid
The invention belongs to the technical field of microorganisms, and particularly relates to bifidobacterium animalis for relieving eye allergy and application of the bifidobacterium animalis. The invention provides an application of bifidobacterium animalis subsp. Lactis in preparation of a product for relieving eye allergy, the bifidobacterium animalis subsp. Lactis is Def +, and the preservation number is CGMCC (China General Microbiological Culture Collection Center) No.35798. The Bifidobacterium animalis subsp. Lactis Def < + > provided by the invention can relieve the eye itching symptom, relieve red and swollen eyelids, reduce conjunctiva and cornea injury, relieve eye discomfort, relieve globular conjunctivitis cell infiltration, improve corneal epithelium thickening lesion, improve the anti-inflammatory ability and improve allergic conjunctivitis, keratitis and blepharitis marginata in a targeted manner. The eye drops are high in safety and resistant to gastrointestinal fluid, and a safe and long-acting scheme is provided for eye allergic diseases.
Owner:ZHONGKE WISBIOM(BEIJING)BIOTECHNOLOGY CO LTD

Bifidobacterium animalis subsp. Lactis with antioxidant effect and gastrointestinal fluid tolerance and application of bifidobacterium animalis subsp. Lactis

The invention discloses a bifidobacterium animalis subsp. Lactis reBF17-4 and application thereof, the strain is preserved in the general microbiological center of the China Committee for Culture Collection of Microorganisms on July 3, 2024, and the preservation number of the strain is CGMCC No.31147. The invention further discloses a preparation method of the bifidobacterium animalis subsp. Lactis reBF17-4. The invention further discloses a preparation method of the bifidobacterium animalis subsp. Lactis reBF17-4 and application of the bifidobacterium animalis subsp. Lactis reBF17-4. The bifidobacterium animalis subsp. Lactis reBF17-4 disclosed by the invention has the advantages that the antioxidation effect is relatively strong, the gastrointestinal tract endurance capacity is relatively strong, and the application prospect in the preparation of medicines is huge.
Owner:CHINA AGRI UNIV

Bifidobacterium lactis BA-C44 and application thereof in relieving symptoms of ulcerative colitis

The invention discloses bifidobacterium lactis BA-C44 and application of the bifidobacterium lactis BA-C44 in relieving ulcerative colitis symptoms, the bifidobacterium lactis BA-C44 is preserved in the China Center for Type Culture Collection on December 04, 2023, and the preservation number is CCTCC NO: M 2023447. A product prepared from the bifidobacterium lactis BA-C44 disclosed by the invention has the beneficial effect of relieving symptoms of ulcerative colitis. Besides, the bifidobacterium lactis BA-C44 has good temperature tolerance and gastrointestinal fluid tolerance, is convenient for storage of commercial products after preparation, is easier to survive in intestines and stomach, and achieves the purpose of relieving symptoms of ulcerative colitis, so that the bifidobacterium lactis BA-C44 has a good application prospect.
Owner:ZHONGCHUANGYIKE (SHANGHAI) HEALTH TECHNOLOGY CO LTD +1

Fermentation process and preparation of lactobacillus reuteri L-01

The invention discloses a fermentation process and a preparation of lactobacillus reuteri L-01, and belongs to the field of microorganism preparation.After artificial domestication, bile salt tolerance of the lactobacillus reuteri L-01 is enhanced, the lactobacillus reuteri L-01 can be cultured in gastrointestinal fluid, and the survival rate of 98% or above can still be kept for a long time; the lactobacillus reuteri L-01 disclosed by the invention can play an excellent probiotic function, is beneficial to improving the balance of intestinal flora, has an inhibiting effect on pathogenic bacteria, and reduces the prevalence rate. Besides, after the components of the culture medium are optimized, the domesticated lactobacillus reuteri L-01 also has a certain anti-oxidation effect and is rich in selenium, so that the use value of the lactobacillus reuteri L-01 is increased. The lactobacillus reuteri L-01 fermentation broth is obtained, after a protective agent is added, the more excellent probiotic effect can be guaranteed, the stability of the lactobacillus reuteri L-01 in processing application and transportation storage is enhanced, and the lactobacillus reuteri L-01 fermentation broth has a certain slow-release effect and has a longer acting effect.
Owner:GUANGDONG HINAPHARM PHARMA CO LTD

Phytobacterium plantarum YN-03, product prepared from same and application of product

The invention provides a plant lactobacillus YN-03, a product prepared from the plant lactobacillus YN-03 and application, and belongs to the technical field of biological medicine, the plant lactobacillus YN-03 is preserved in China Center for Type Culture Collection on October 22, 2024, and the preservation number is CCTCC NO: M 20242301; the name of Latin is Lactiplantibacillus plantarum YN-03, and the name of Latin is Lactiplantibacillus plantarum YN-03; the gene sequence of the 16srRNA of the phytobacterium plantarum YN-03 is as shown in SEQ ID NO. 1, and the phytobacterium plantarum YN-03 has good gastrointestinal fluid and cholate tolerance. According to the plant lactobacillus YN-03, the product prepared from the plant lactobacillus YN-03 and the application of the plant lactobacillus YN-03, the plant lactobacillus YN-03 has the characteristic of high yield of GABA (gamma-aminobutyric acid) and shows potential application value in the aspect of relieving anxiety and depression.
Owner:INNER MONGOLIA AGRICULTURAL UNIVERSITY

Fermented lactobacillus mucus capable of prolonging life, resisting aging and resisting oxidation as well as product and application of fermented lactobacillus mucus

The invention discloses application of fermented lactobacillus mucus capable of prolonging life, resisting aging and resisting oxidation, and belongs to the technical field of functional strains. The preservation numbers of the lactobacillus mucus A21224 and the lactobacillus mucus A21227 are GDMCC No: 62958 and GDMCC No: 62962 respectively, and the lactobacillus mucus A21224, the lactobacillus mucus A21227 and the lactobacillus mucus A21227 are used for The two strains can remarkably prolong the service life of nematodes, have good antioxidant effect and heat stress resistant effect, can prolong the service life of the nematodes by 40% in a strong oxidation environment, and can prolong the service life of the nematodes by 28.57% under the stress of a thermal environment. In addition, the lactobacillus mucus A21224 and the lactobacillus mucus A21227 both show an excellent anti-aging effect in the late stage of the nematodes. Meanwhile, the two strains have certain gastrointestinal fluid-resistant and cholate-resistant effects, can be colonized in intestinal tracts, have no hemolysis phenomenon and are high in safety.
Owner:AIAGE LIFE SCI CORP LTD

Lactobacillus gasseri strain A21120 with anti-oxidation, anti-inflammatory and anti-tumor functions as well as probiotic agent and application of lactobacillus gasseri strain A21120

The invention provides a lactobacillus gasseri strain A21120 with anti-oxidation, anti-inflammatory and anti-tumor functions as well as a probiotic agent and application of the lactobacillus gasseri strain A21120, and belongs to the technical field of functional microorganisms. The strain A21120 is separated and screened from intestinal feces of healthy old people of 100 years old, and belongs to lactobacillus gasseri through morphological identification and molecular identification. The strain has good gastrointestinal fluid resistance and bovine choline resistance and has the potential of colonizing intestinal tracts. The lactobacillus gasseri strain A21120 provided by the invention has bacteriostatic activity, anti-inflammatory activity, anti-oxidation activity and anti-tumor activity, and provides a new way for treatment of clinical related diseases, drug development and preparation of in-vitro preparations or daily necessities.
Owner:GUANGXI ACAD OF SCI +1

Lactobacillus amyloliquefaciens FMNS13 and application thereof

The invention discloses lactobacillus amyloliquefaciens FMNS13 and application thereof, and belongs to the technical field of probiotics. The invention provides a strain of lactobacillus amyloliquefaciens FMNS13, the strain has good endurance capacity to gastrointestinal fluid and inhibition capacity to pathogenic bacteria, and the strain and metabolites thereof also have good oxidation resistance, can be used for preparing antioxidant drugs and health care products, or can be used for preparing freeze-dried fruit and vegetable products, and has wide application. The invention also optimizes the freeze-drying protective agent of the lactobacillus amyloliquefaciens FMNS13, so that the survival rate of viable bacteria in the lactobacillus amyloliquefaciens FMNS13 freeze-dried powder prepared by using the freeze-drying protective agent can reach 89.72%.
Owner:NANJING UNIV OF FINANCE & ECONOMICS

Lactobacillus buchneri and application thereof in preparation of nutritional and healthy fruit and vegetable juice

The invention discloses a Lactobacillus buchneri strain with high yield of gamma-aminobutyric acid and application of the Lactobacillus buchneri strain in preparation of nutritional and healthy fruit and vegetable juice. The strain is Lactobacillus buchneri GM3, and is preserved in the Guangdong Microbial Culture Collection Center on January 9, 2025, and the preservation number of the strain is GDMCC No: 65737. The invention further discloses a preparation method of the Lactobacillus buchneri strain. The strain not only has the capacity of producing gamma-aminobutyric acid at high yield, but also has good acid resistance, cholate resistance and gastrointestinal fluid resistance, and is very suitable for fermentation production of fermented fruit and vegetable juice. The contents of gamma-aminobutyric acid and flavonoid substances in fruit and vegetable juice fermented by the strain are greatly increased, and the nutritional value of the fruit juice is remarkably increased; moreover, the contents of alkaloid substances and total sugar are remarkably reduced, so that the tea is healthier, and the flavor is better and more unique. The Lactobacillus buchneri GM3 is a safe lactic acid bacterium, and the Lactobacillus buchneri GM3 and the technology for producing fruit and vegetable juice through fermentation of the Lactobacillus buchneri GM3 have very good application value and market prospect.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY +1

Phytobacterium plantarum microcapsule as well as preparation method and application thereof

According to the technology, lily starch, citrus pectin and whey protein are used as wall materials, and plant lactobacillus is embedded by adopting a low-temperature spray drying process; the method mainly comprises the following steps: preparation of a bacterial suspension, preparation of a wall material solution, preparation of a microcapsule solution, and low-temperature spray drying to prepare the microcapsule. According to the preparation technology of the stably packaged phytobacterium plantarum microcapsule, the microcapsule after spray drying is high in viable count, high in gastrointestinal fluid tolerance and stable in storage, and the problem that the activity of thalli is reduced or even inactivated in the production processing, storage transportation and in-vivo digestion processes of phytobacterium plantarum and products thereof can be effectively solved; the prepared microcapsule can be used as a probiotic agent, can be applied to foods such as cheese, yoghourt, ice cream, milk, chocolate, lactic acid bacteria beverage, baked products and the like, is beneficial to promoting the healthy development of the probiotic industry, and has obvious economic benefits and social benefits.
Owner:NANCHANG UNIV

Shell-core double-layer gel ball with targeted delivery function as well as preparation method and application of shell-core double-layer gel ball

The invention discloses a shell-core double-layer gel ball with a targeted delivery function and a preparation method and application thereof, belongs to the technical field of shell-core gels, and provides the preparation method of the shell-core double-layer gel ball with the targeted delivery function, and the preparation method comprises the following steps: mixing a polysaccharide aqueous solution and a protein aqueous solution in an isovolumetric manner to obtain a composite gel precursor solution, and performing water bath treatment to obtain the shell-core double-layer gel ball with the targeted delivery function. Dropwise adding the thermal copolymerization product into a calcium chloride aqueous solution, curing to obtain a single cross-linked gel ball, immersing the single cross-linked gel ball into a tannic acid aqueous solution, and curing to obtain a shell-core double-layer gel ball. The polysaccharide is used as a core skeleton, and the protein and tannic acid compound is used for filling outer layer pores to form a shell with a compact double-penetrating network structure, so that the barrier property on oxygen and gastrointestinal fluid is remarkably improved, and the storage stability and the in-vivo colonization effect can be improved.
Owner:SANYA INSTITUTE OF NANJING AGRICULTURAL UNIVERSITY

Bifidobacterium adolescentis YF-01 and application thereof in fermented milk

The invention relates to the technical field of biological medicine, and discloses bifidobacterium adolescentis YF-01 and application thereof in fermented milk. The bifidobacterium adolescentis YF-01 is separated from adult excrement and is preserved in the China Center for Type Culture Collection, and the preservation number is CCTCC NO: M 20251308. Experiments prove that the bifidobacterium adolescentis YF-01 has good gastrointestinal fluid tolerance, the survival rate of the bifidobacterium adolescentis YF-01 can reach 90.1% after simulated gastric fluid treatment for 3 h, and the survival rate of the bifidobacterium adolescentis YF-01 can reach 72% after simulated intestinal fluid treatment for 4 h The strain has the self-aggregation rate of 88.83% and the hydrophobicity of 79.41%, has remarkable scavenging capacity on DPPH free radicals and hydroxyl free radicals, shows good antioxidant activity and adhesion capacity, and provides a theoretical basis for application of the strain in fermented milk. The strain and metabolites thereof can be used for preparing food, medicines or health care products capable of regulating intestinal flora and enhancing oxidation resistance, and have remarkable application potential in development of functional fermented milk products.
Owner:INNER MONGOLIA AGRICULTURAL UNIVERSITY

Phytobacterium plantarum HUCF11 and application thereof in preparation of medicine for relieving ferroptosis

The invention discloses a plant lactobacillus HUCF11 strain and application thereof in preparation of a medicine for relieving ferroptosis, and belongs to the technical field of functional microorganisms. In order to excavate a microecological preparation for treating ferroptosis-related diseases, the invention separates a plant lactobacillus HUCF11 strain, and the strain HUCF11 strain is proved to have better tolerance and no toxicity to artificial gastrointestinal fluid through a simulated gastrointestinal fluid experiment and a toxicity evaluation experiment; the establishment of a drosophila ferroptosis model proves that the following symptoms caused by ferroptosis can be improved by taking the strain HUCF11: degeneration of action ability, shortening of sleep duration, anxiety and unease, reduction of DPPH free radical scavenging ability and antioxidant ability and reduction of glutathione level; the expression of an intestinal tissue ferroptosis related gene gpx4 is abnormal; and the intestinal flora structure is disordered. The strain HUCF11 provided by the invention can be used for preparing medicines for relieving ferroptosis, and a new way is opened up for relieving ferroptosis.
Owner:HARBIN UNIV OF COMMERCE

Bifidobacterium longum GY2 with anti-hepatitis B virus function and application of bifidobacterium longum GY2

The invention discloses bifidobacterium longum GY2 with an anti-hepatitis B virus function and application of the bifidobacterium longum GY2. The preservation number of the bifidobacterium longum GY2 is as follows: GDMCC No: 64873. The bifidobacterium longum GY2 provided by the invention can inhibit the replication of HBV DNA and the generation of HBeAg and HBsAg in vivo and in vitro, can delay the occurrence of tumor of tumor-bearing nude mice, has certain gastrointestinal fluid tolerance, can be colonized in intestinal tracts, effectively antagonizes various pathogenic bacteria, is sensitive to various antibiotics, does not have hemolytic activity, has good probiotic characteristics and safety, and can be used for preparing a medicine for treating tumor-bearing nude mice. And in addition, the in-vivo and in-vitro functions are remarkable, so that the polypeptide has relatively great application potential and utilization value in the aspect of developing functional foods or medicines for preventing and treating HBV infection and related diseases and the like.
Owner:GUANGDONG INST OF MICROBIOLOGY GUANGDONG DETECTION CENT OF MICROBIOLOGY +1

Lactobacillus mucilaginosus BL-SWN1 and application thereof

The invention provides fermented lactobacillus mucus BL-SWN1 and application thereof, the fermented lactobacillus mucus BL-SWN1 is screened from naturally fermented soybean clear water, is preserved in China General Microbiological Culture Collection Center (CGMCC) on January 6, 2025, is named as Limosilicilla fermentum in taxonomy, has a preservation number of CGMCC No.33307, and belongs to the technical field of microorganisms. The lactobacillus mucus BL-SWN1 has good acid production capacity, gastrointestinal fluid and cholate tolerance, bacteriostatic activity and nitrite degradation capacity, the pH value of a culture medium can be reduced to about 4.3 within 24 h of culture, and the nitrite degradation rate reaches 95% or above. The fermentation lactobacillus mucus BL-SWN1 can be applied to vegetable fermentation products such as pickled Chinese cabbages and pickled vegetables, can also be suitable for the fermentation process of dairy products and meat products, has a wide application prospect in the food industry, and particularly has remarkable advantages in the aspect of development of healthy fermentation foods.
Owner:BOHAI UNIV

A probiotic microcapsule and its preparation method

This invention discloses a probiotic microcapsule and its preparation method, belonging to the field of microcapsule preparation technology. The preparation method includes the following steps: (1) dissolving Sophora japonica extract in water, stirring, adding sodium alginate, and stirring again to obtain a wall material solution; (2) centrifuging and washing the activated probiotics, preparing a bacterial suspension, mixing it with the wall material solution obtained in step (1), stirring, and obtaining a wall material bacterial suspension; (3) adding the wall material bacterial suspension obtained in step (2) to a calcium chloride solution and letting it stand, then adding the formed gel to a chitosan solution, stirring, washing, and obtaining the final product. The preparation process of this invention is simple and convenient, and the raw materials are inexpensive and easy to obtain, which can effectively reduce the production cost of microcapsules, facilitate large-scale industrial production and application promotion, effectively improve the biocompatibility, biodegradability, mechanical strength and encapsulation rate of microcapsules, and enhance the storage stability and resistance to gastrointestinal fluid stress of microcapsules.
Owner:CHENGDU UNIV

Lactobacillus mucilaginosus and application thereof

The invention discloses lactobacillus mucilaginosus and application thereof, and belongs to the technical field of microbial fermentation. The invention provides a lactobacillus mucus WX20 which is preserved in the Guangdong Microbial Culture Collection Center on September 12, 2024, and the preservation number of the lactobacillus mucus WX20 is GDMCC No: 65083. The lactobacillus mucus WX20 has the advantages that the lactobacillus mucus WX20 is preserved in the Guangdong Microbial Culture Collection Center on September 12, 2024; the strain obtained by screening can effectively degrade inosine and guanosine and inhibit the activity of xanthine oxidase, and has good tolerance in a simulated gastrointestinal fluid environment. When the strain is used for fermenting the leaf mustard, the fermentation period of the fermented leaf mustard can be shortened, a product prepared by utilizing the strain has the activity of degrading inosine and guanosine and inhibiting xanthine oxidase, a microbial inoculum and pickles can remarkably reduce the blood uric acid level of a mouse with hyperuricemia, and the strain has considerable application potential and high market value.
Owner:KUNMING UNIV OF SCI & TECH

Phytobacterium plantarum JN-7, bacterium powder, preparation method, probiotic composition and application thereof

The invention relates to a plant lactobacillus JN-7, bacterial powder, a preparation method, a probiotic composition and application thereof. According to the application, a new plant lactobacillus strain is obtained through screening, the new plant lactobacillus strain is named as plant lactobacillus JN-7, and the preservation number is CGMCC (China General Microbiological Culture Collection Center) No.30605. Basic characteristic analysis (growth curve, acid resistance, cholate resistance and gastrointestinal fluid resistance), safety evaluation (antibiotic sensitivity, hemolysis capability, toxin production capability and cytotoxicity), adhesiveness evaluation, anti-inflammatory action evaluation, production performance evaluation (fermentation yield and freeze-drying yield) and stability test (accelerated storage stability test) of the strain are carried out; it is found that the plant lactobacillus JN-7 is a safe strain and has excellent production performance, high stability and an anti-inflammatory effect. The bacterial powder produced by the bacterial strain can keep stable and active for a long time.
Owner:ADM (SHANGHAI) MANAGEMENT CO LTD

Eggshell membrane polypeptide with DPP-IV enzyme inhibitory activity and application of eggshell membrane polypeptide in blood glucose regulation

The invention discloses eggshell membrane polypeptide with DPP-IV enzyme inhibitory activity and application of the eggshell membrane polypeptide in blood glucose regulation, and belongs to the technical field of biology. The amino acid sequence of the eggshell membrane polypeptide is as shown in SEQ ID NO. 1. According to the invention, a high-activity polypeptide Ala-Pro-Ser-Pro-Trp-Glu is separated and identified from an eggshell membrane, the polypeptide is proved to have certain DPP-IV inhibition ability both in cells and outside cells, the stable DPP-IV inhibition activity is maintained in an in-vitro simulated gastrointestinal fluid environment, and a theoretical basis is provided for research and development of novel diabetes drugs.
Owner:XINJIANG XIPA HEALTH FOOD CO LTD +1

Phytobacterium plantarum strain A21337 with functions of inhibiting bacteria and secreting 5-hydroxytryptamine as well as probiotic agent and application thereof

The invention provides a lactobacillus plantarum strain A21337 with the functions of inhibiting bacteria and secreting 5-hydroxytryptamine, a probiotic agent of the lactobacillus plantarum strain A21337 and application of the lactobacillus plantarum strain A21337, and belongs to the technical field of functional microorganisms. The invention provides application of phytobacterium plantarum or a microbial agent containing the phytobacterium plantarum in preparation of a product resisting pathogenic bacteria and / or rich in 5-hydroxytryptamine. According to the invention, a plant lactobacillus strain A21337 is separated from intestinal feces of healthy 100-year old people in Guangxi province, has the characteristics of secreting 5-hydroxytryptamine and inhibiting pathogenic bacteria, and has good tolerance to gastrointestinal fluid. Therefore, the strain A21337 or the probiotic agent containing the strain A21337 provides a new means for preparing a product which is resistant to pathogenic bacteria and / or rich in 5-hydroxytryptamine.
Owner:GUANGXI ACAD OF SCI +1

Preparation and application of sour horse milk-derived lactobacillus plantarum, enterococcus faecalis and composite freeze-dried microbial inoculum with synergistic probiotic function

PendingCN121294270AAntibacterial agentsBacteriaBiotechnologyMare milk
According to the invention, the traditional fermented koumiss in Xinjiang is collected, two novel multifunctional probiotic strains, namely, the lactobacillus plantarum SR6 GDMCC NO.66817 strain and the enterococcus faecalis SM5 GDMCC NO.66816 strain with good compatibility are separated and screened out, and the two strains have the characteristics of reducing blood fat, reducing cholesterol, removing triglyceride, resisting oxidation and antagonizing pathogenic bacteria, and have the characteristics of good cholate and gastrointestinal tract tolerance, high survival rate and good safety. The growth characteristics and compatibility of the two strains are improved; the inhibition rate of cholesterol esterase and pancreatic lipase; the method comprises the following steps: evaluating the triglyceride removal rate, antioxidant activity, pathogenic bacterium resistance, artificially simulated gastrointestinal fluid tolerance, strain drug resistance and safety, compounding lactobacillus plantarum SR6 and enterococcus faecalis SM5 strains according to a ratio of 1: 1 to prepare a freeze-dried bacterial agent, and keeping good survival rate (pgt; 0.05) and functional characteristics, the strain can be used as a functional direct vat set starter and is directly applied to production of fermented dairy products, and the biological activity of food is improved.
Owner:YILI NALA DAIRY GRP CO LTD +1